The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?
In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.
“Five years after the initial accelerated approval, you should have a definitive answer,” said Dr. Ezekiel Emanuel, a cancer specialist and bioethicist at the University of Pennsylvania who was not involved in the research. “Thousands of people are getting those drugs. That seems a mistake if we don’t know whether they work or not.”
The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs.
It allows the FDA to grant early approval to drugs that show promising initial results for treating debilitating or fatal diseases. In exchange, drug companies are expected to do rigorous testing and produce better evidence before gaining full approval.
Related articles:
Related suggestion:
Lottery, gambling bill heads to Alabama legislative conference committee for negotiationsShane Bowen has big shoes to fill in replacing Wink Martindale as Giants defensive coordinatorRory McIlroy debunks LIV Golf rumors. Greg Norman claims unanimous support during Masters tripAnalysis: Kyle Larson settling in quickly as preparation continues for Indianapolis 500 debutNHL says it set a singleTrump rips judge for warning he may have to SKIP Barron's high school graduation: ExIt was one of the most joyousBrowns QB Deshaun Watson throwing full speed after shoulder surgery, timetable for return unknownFacing a Republican revolt, House Speaker Johnson pushes ahead on US aid for Ukraine, alliesCaitlin Clark fever is spreading. Indiana is all
2.7724s , 6498.7734375 kb
Copyright © 2024 Powered by Study: Many cancer drugs unproven 5 years after accelerated approval ,Culture Chronicle news portal